Blood Proteome Profiling Reveals Biomarkers and Pathway Alterations in Fragile X PM at Risk for Developing FXTAS.
FXTAS
biomarker
blood proteomic
fragile X-associated tremor/ataxia syndrome
pathways
premutation
protein alterations
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
30 Aug 2023
30 Aug 2023
Historique:
received:
15
07
2023
revised:
18
08
2023
accepted:
21
08
2023
medline:
11
9
2023
pubmed:
9
9
2023
entrez:
9
9
2023
Statut:
epublish
Résumé
Fragile X-associated Tremor/Ataxia Syndrome (FXTAS) is a neurodegenerative disorder associated with the
Identifiants
pubmed: 37686279
pii: ijms241713477
doi: 10.3390/ijms241713477
pmc: PMC10488017
pii:
doi:
Substances chimiques
Proteome
0
Biomarkers
0
FMR1 protein, human
0
Fragile X Mental Retardation Protein
139135-51-6
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NINDS NIH HHS
ID : R01 NS110100
Pays : United States
Organisme : NIH HHS
ID : S10 OD026918
Pays : United States
Références
J Alzheimers Dis. 2020;75(2):429-436
pubmed: 32280104
Front Neurosci. 2018 Jun 25;12:379
pubmed: 29988561
Cell Rep. 2019 Aug 20;28(8):2111-2123.e6
pubmed: 31433986
Front Psychiatry. 2021 Aug 16;12:691717
pubmed: 34483988
Eur J Hum Genet. 2009 Oct;17(10):1359-62
pubmed: 19367323
Nat Rev Neurol. 2016 Jul;12(7):403-12
pubmed: 27340021
JAMA. 2004 Jan 28;291(4):460-9
pubmed: 14747503
Anal Chim Acta. 2015 Jul 23;885:1-16
pubmed: 26231889
J Lipid Res. 2016 Apr;57(4):546-62
pubmed: 26900161
Mol Cell Neurosci. 2010 Jun;44(2):154-64
pubmed: 20230896
Neural Regen Res. 2022 Dec;17(12):2675-2676
pubmed: 35662205
Front Neurol. 2020 Apr 03;11:233
pubmed: 32308643
Microsc Res Tech. 2023 Feb;86(2):223-231
pubmed: 36354743
Front Mol Neurosci. 2021 Dec 20;14:788695
pubmed: 34987360
Cerebellum. 2022 Feb;21(1):99-100
pubmed: 34505966
Front Neurol. 2019 Nov 07;10:1179
pubmed: 31787927
Neurobiol Dis. 2020 Mar;136:104740
pubmed: 31927143
Am J Hum Genet. 2000 Jan;66(1):6-15
pubmed: 10631132
J Mol Diagn. 2008 Jan;10(1):43-9
pubmed: 18165273
Acta Neuropathol Commun. 2019 Sep 3;7(1):143
pubmed: 31481131
Front Neurosci. 2022 May 06;16:840266
pubmed: 35600620
J Clin Psychiatry. 2006 Jan;67(1):87-94
pubmed: 16426093
PLoS Comput Biol. 2017 Nov 3;13(11):e1005752
pubmed: 29099853
Neuromuscul Disord. 2021 Nov;31(11):1186-1193
pubmed: 34325999
Sci Rep. 2020 Jul 6;10(1):11099
pubmed: 32632326
Neurotherapeutics. 2018 Jul;15(3):728-741
pubmed: 29736859
Front Mol Biosci. 2021 Jan 29;7:600840
pubmed: 33585555
Sci Rep. 2020 Feb 12;10(1):2479
pubmed: 32051502
World J Biol Chem. 2021 Sep 27;12(5):57-69
pubmed: 34630910
FASEB J. 2020 Dec;34(12):16676-16692
pubmed: 33131090
Front Oncol. 2020 May 15;10:605
pubmed: 32500021
Lab Invest. 2022 Nov;102(11):1170-1181
pubmed: 35922478
Nat Rev Dis Primers. 2017 Sep 29;3:17065
pubmed: 28960184
Front Aging Neurosci. 2020 Jul 10;12:215
pubmed: 32754029
Metabolism. 2002 Mar;51(3):366-71
pubmed: 11887175
Methods Mol Biol. 2019;1942:173-189
pubmed: 30900185
Clin Chem. 2010 Mar;56(3):399-408
pubmed: 20056738
Int J Mol Sci. 2020 Jun 20;21(12):
pubmed: 32575683